1 Pharmacy Practice Incentive (PPI) Program Clinical Intervention Definitions $97 million over the life of the Agreement (5 years)
2 Clinical Intervention - Definitions A clinical intervention: is a professional activity by the pharmacist directed towards improving the quality use of medicines and resulting in a recommendation for a change in the patient s: medication therapy; or medication-taking behaviour; or means of administration
3 Definitions continued A clinical intervention is the process of a pharmacist identifying, and making a recommendation in an attempt to prevent or resolve, a Drug Related Problem (DRP). There may be circumstances where other pharmacy staff may initially identify a possible DRP. This MUST be referred to a pharmacist to actually perform and document the intervention.
4 Definitions continued A DRP is an event or circumstance involving drug treatment that actually or potentially interferes with the patient experiencing an optimum outcome of medical care.
5 Definitions continued A clinical intervention MUST relate to a medicine, however the intervention does not need to occur at the time the medicine is dispensed or sold. A medicine must be included on the Australian Register of Therapeutic Goods (ARTG) available at ( and can fall under any of the following categories: Prescripti on Non- Prescription Over the counter (OTC) Scheduled (S2/S3) non-scheduled Complementa ry NOTE: For easy identification all medicines have either AUST L or AUST R on the label.
6 Under PPI a clinical intervention does NOT include: Routine prescriptionrelated counselling Generic medicine substitution CMI provision Definitions continued Activities undertaken during: HMR; RMMR; Medscheck; or Diabetes Medscheck services
7 Pharmacy Practice Incentive (PPI) Program Clinical Intervention Pharmacy Eligibility
8 Eligibility to participate and receive incentive payments Approved Section 90 pharmacy Maintain registration at Maintain accreditation by an approved Pharmacy Accreditation Program (such as QCPP) Must continue to publicly display and comply with the Community Pharmacy Service Charter and Customer Service Statement Meet all PPI Program requirements as outlined in the PPI Program Specific Guidelines (including QCPP requirements) Retain all records for auditing purposes for min. 2 years
9 Pharmacy Practice Incentive (PPI) Program Clinical Intervention Accreditation Requirements
10 Accreditation Requirements Eligible Community Pharmacies MUST deliver and record Clinical Interventions to the quality Standard. The Quality Care Pharmacy Program (QCPP) will audit all participating pharmacies every two years (accreditation cycle) to ensure this requirement is met.
11 Accreditation Requirements continued QCPP tools and resources available to assist with the delivery and recording of Clinical Interventions to the quality Standard. QCPP Requirements Manual (2011 edition) QCPP Fast Track resources Excellence Newsletter (bi-monthly)
12 Accreditation Requirements continued Participating pharmacies MUST develop a Clinical Interventions Policy as outlined in the QCPP Requirements Manual. P2H Clinical Interventions Policy Develop your policy File policy in your Operations Manual Update Table of Contents Source: Extract from the QCPP Requirements Manual (2011 Edition)
13 Accreditation Requirements continued Participating pharmacies MUST meet the mandatory requirements in the Clinical Interventions Checklist outlined in the QCPP Requirements Manual. T2G Clinical Interventions Checklist (mandatory requirements) Maintain access to approved guidelines for clinical interventions (i.e. PSA Standards and guidelines) Maintain and follow a system for providing clinical interventions (i.e. Clinical Interventions Policy) Maintain and follow a system for communicating with prescribers and other relevant health care professionals Maintain and follow a recording system for clinical interventions including the recording of specific details (If participating in the PPI Program the D.O.C.U.M.E.N.T. classification system MUST be used for recording) Source: Extract from the QCPP Requirements Manual (2011 Edition)
14 Accreditation Requirements continued Source: Extract from the QCPP Requirements Manual (2011 Edition)
15 Pharmacy Practice Incentive (PPI) Program Clinical Intervention Recording
16 Recording Clinical Interventions The D.O.C.U.M.E.N.T. classification system MUST be used when recording Clinical Interventions under PPI, however interventions under the M.E.N. components of the classification system cannot be claimed.
17 D.O.C.U.M.E.N.T. Classification system Drug Related Problem D Drug Selection O Over or under-dose C Compliance U Undertreated M Monitoring E Education N Not Classifiable T Toxicity or adverse reaction Recording continued All classifications should be used when delivering and recording clinical interventions however the M.E.N. components of this classification system cannot be claimed under the PPI Program.
18 Drug Related Problem continued D Drug Selection Duplication (D1) Drug Interaction (D2) Wrong Drug (D3) Incorrect strength (D4) Inappropriate dosage form (D5) Contraindication apparent (D6) No indication apparent (D7) Other drug selection problem (D0) O Over or under dose Prescribed dose too high (O1) Prescribed dose to low (O2) Incorrect or unclear dosing instructions (O3) Other dose problem (O4) C Compliance Underuse by patient (C1) Overuse by patient (C2) Erratic use of medication (C3) Recording continued Intentional drug misuse including nonprescription medicines (C4) Difficulty using dosage form (C5) Other compliance problem (C0) U Undertreated Condition undertreated (U1) Condition untreated (U2) Preventive therapy required (U3) Other undertreated indication problem (U0) T Toxicity or Adverse Reaction Toxicity, allergic reaction or adverse effect present (T1)
19 D.O.C.U.M.E.N.T. Classification system continued Recommendation Recording continued Change of therapy Referral required Provision of information Monitoring Other When recording clinical interventions under the D.O.C.U.M.E.N.T. classification system you must also record a recommendation as outlined in the PSA Standards and guidelines
20 D.O.C.U.M.E.N.T. Classification system continued Recording continued Recommendation Change of therapy Dose increase (R1) Dose decrease (R2) Drug change (R3) Drug formulation change (R4) Drug branch change (R5) Dose frequency/schedule change (R6) Prescription not dispensed (R7) Other changes to therapy (R8) Referral required Refer to prescriber (R9) Refer to hospital (R10) Provision of information Education or counselling session (R13) Written summary of medications (R14) Recommend dose administration aid (R15) Other written information (R16) Monitoring Monitoring: Laboratory (R17) Monitoring: Non-laboratory test (R18) Other No recommendation necessary (R19) Refer for medication review (R11) Other referral required (R12)
21 The Pharmaceutical Society of Australia (PSA) has developed: Recording continued Standards and guidelines for pharmacists performing clinical interventions; and An online learning module on clinical interventions These include an explanation of the D.O.C.U.M.E.N.T. classification system and examples of how to use it. Available from and
22 Recording continued The following situations are clinical interventions and should be recorded under the D.O.C.U.M.E.N.T. classification system: The pharmacist identifies potential over-use or duplication of medicines, or overtreatment of conditions. The pharmacist identifies the need for preventive therapy, such as the requirements for adequate intake of calcium and vitamin D in a consumer with osteoporosis. The pharmacist identifies a medical condition (e.g. poorly controlled hypertension) which may require enhanced therapy or improved medication adherence. Source: Extract from the PSA Standard and guidelines for pharmacists performing clinical interventions
23 Upon a consumer request for non-prescription pain relief subsequent to the use of an HMG CoA reductase inhibitor (statin), the pharmacist uncovers a possible myopathy-associated DRP. Recording continued The following situations are clinical interventions and should be recorded under the D.O.C.U.M.E.N.T. classification system: A consumer requests further information regarding medicine or disease management. The pharmacist dispenses a repeat prescription from another pharmacy, and identifies that it had been previously dispensed incorrectly. Source: Extract from the PSA Standard and guidelines for pharmacists performing clinical interventions
24 Routine consumer counselling and provision of CMI, such as when a consumer has been dispensed a new medicine. Recording continued Many activities undertaken by pharmacists are NOT clinical interventions and should NOT be claimed under the PPI Program, these include: Routine assessment or management of minor ailments, such as provision of symptom relief for cold and flu, or assessment and treatment of allergic rhinitis. Substitution of medication brand unless the recommended brand has a unique characteristic to assist in the resolution of a DRP (e.g. calendar pack, braille, glutenfree). events (e.g. Administrative medicine ordering, prescription processing, determining PBS eligibility). Source: Extract from the PSA Standard and guidelines for pharmacists performing clinical interventions
25 Recording continued The PSA Standards and guidelines also include: a Paper-based recording for clinical interventions template; and downloadable DOCUMENT DRP and recommendation classification codes table
26 Recording continued Pharmacies can also record clinical interventions using an electronic system. The use of an electronic system will deliver a range of benefits as outlined: Ability to create reports for claiming incentives Providing evidence for pharmacy accreditation program assessments Integrating with the Personally Controlled Electronic Health Record (PCEHR), when available Facilitating the reporting of adverse drug reactions and Using the data for evaluation.
27 Electronic systems currently available to record clinical interventions: Guildcare Aquarius Corum FRED NOTE: when using any electronic system to record clinical interventions under the PPI Program ensure you use the D.O.C.U.M.E.N.T. classification system. Recording continued This list of electronic systems (software) available to record clinical interventions was correct as at June 2012
28 Date of the intervention Pharmacist performing intervention Patient identifier (does not need to be patient name, can be unique number) Patient age range (not specific age) Patient gender Medicines involved Recording continued Whether you use a paper-based or electronic system to record clinical interventions the information recorded should be the same. You must include: Clinical notes detailing the intervention and any relevant medical history Classification of the intervention Recommendation/follow-up actions Any communication with other health care professionals or consumer/agent NOTE: The above information to be recorded is consistent across the PPI Program, QCPP Clinical Interventions Checklist and PSA Standard and guidelines Any other relevant information
29 Pharmacy Practice Incentive (PPI) Program Clinical Intervention Claiming
30 Clinical Interventions Incentive Payments Eligible pharmacies will be paid 4 times per year for meeting the PPI and QCPP requirements when delivering a clinical intervention. Payments are calculated based on a complex formula for each claiming period that considers: the available funding pool for that period; no. of pharmacies claiming for that period; service volume (no. of Clinical Interventions for that period); and claimable prescription volume for that period.
31 Claiming Incentive Payments Periodic payments 4 times per year Eligible Community Pharmacies must lodge a VALID Pharmacy Practice Incentive Periodic payment application form (claim form) to Medicare by the Claim Due Date for each eligible Claiming Period NOT fee for service Claim form available on the Medicare website or
32 Claiming continued Must provide the total number of clinical interventions recorded under D.O.C.U.T. for the eligible Claiming Period.
33 The claim form MUST be completed correctly and lodged with Medicare no later than the Claim Due Date for each eligible Claiming Period to be VALID. Pharmacy name Pharmacy address Claiming continued Pharmacy PBS Approval Number Eligible Claim Period applicable and year Total number of clinical interventions recorded under D.O.C.U.T. classifications throughout the claiming period Source: Extract from the QCPP Requirements Manual (2011 Edition) Authorised Pharmacist s name, signature and date
34 IMPORTANT If your pharmacy has a change in circumstances such as a change of PBS approval number you MUST: 1.Notify QCPP within 14 days and complete a Change of Pharmacy Status form available at and fax to QCPP on AND Claiming continued 2.Amend the pharmacy s PPI Registration on the 5CPA website using the link contained in the 5CPA Registration Receipt Notification and your 4 digit PIN code. If your PBS approval number is not current with QCPP or on the PPI registration system your PPI payments will be delayed.
35 Pharmacy Practice Incentive (PPI) Program Clinical Intervention Pathway to other Professional Services
36 Pathway to other Professional Services Performing clinical interventions may provide a pathway to other professional services if appropriate, such as: Dose Administration Aids HMR or RMMR Medscheck or Diabetes Medscheck Staged Supply service Disease State Management and/or Screening and Risk Assessment services DR P
37 Pharmacy Practice Incentive (PPI) Program Clinical Intervention Working with Others
38 Clinical Interventions and Working with Others Collaborations with other health professionals registered with AHPRA resulting from a clinical intervention should be documented as evidence for the Working with Others priority area if the pharmacy is participating in this PPI. To perform clinical interventions in an efficient manner, it is critical to have effective collaboration with, and communication between, relevant members of the healthcare team, including GPs, medical specialists, other pharmacists, consumers, carers, nurses and other healthcare providers. * * Extract from the PSA Standard and guidelines for pharmacists performing clinical interventions
39 Official PPI Program Information and Resources PPI Registration PPI Program Specific Guidelines Forms (claim form and declaration) The Charter (and Statement) FAQs Brochures (PPI and Charter) Factsheets (PPI Priority Areas, Claiming and Recording) DAA Worksheet Support: 5cpa Help Line or and State Based officers (Guild Branches)
40 Additional resources to assist in delivering the PPI Program Pharmacy Accreditation Program (QCPP) QCPP Requirements Manual -Policies -Procedures -Templates QCPP Fast Track resources QCPP Excellence Newsletter Support: QCPP State Managers QCPP Helpline Professional Practice Standards and guidelines Standards and guidelines for pharmacists providing DAAs, Clinical Interventions and Staged Supply. Online learning for Clinical Interventions and Staged Supply Paper template for recording Clinical Interventions Electronic recording options currently available Guildcare Clinical Interventions Staged Supply Primary Health Care Working with Others Dispensing and other Software Clinical Interventions recording e.g. Aquarius, Corum, Fred, etc.
Programme Specific Guidelines Pharmacy Practice Incentives (PPI) Current as at February 2014 This Project is funded by the Australian Government Department of Health as part of the Fifth Community Pharmacy
Community Pharmacy Roadmap Program Development Template Program/Service: Quadrant: 1. Program/Service Description QUM and Continuity of Care A Prescribed Medicines Services and Programs a) Background The
PCNE Classification for Drug related problems (revised 22-04-03 vm) V4.00 2003 Pharmaceutical Care Network Europe Foundation This classification can freely be used in Pharmaceutical Care Research and practice,
Classification for Drug related problems (revised 14-01-2010vm) 2003-2010 Pharmaceutical Care Network Europe Foundation This classification can freely be used in Pharmaceutical Care Research and practice,
Protocol October 2015 Version 1.3 Table of Contents Service Information... 2 Service objective... 2 Clinical service overview... 2 Documentation... 3 Staff Roles... 3 Facilities to support the program...
Protocol October 2015 Version 1.1 Table of Contents Service Information... 2 Service objective... 2 Clinical service overview... 2 Documentation... 2 Staff Roles... 3 Facilities to support the program...
Health Professions Act BYLAWS SCHEDULE F PART 3 Residential Care Facilities and Homes Standards of Practice Table of Contents 1. Application 2. Definitions 3. Supervision of Pharmacy Services in a Facility
Professional Standards and Guidance for the Sale and Supply of Medicines About this document The Code of Ethics sets out seven principles of ethical practice that you must follow as a pharmacist or pharmacy
Quality Management AIDS Pharmaceutical Assistance (Local) Broward County/Fort Lauderdale Eligible Metropolitan Area (EMA) The creation of this public document is fully funded by a federal Ryan White CARE
Sample Service Specifications SSS 1: Care of people with diabetes as part of essential services Service Description Certain aspects of diabetes care fall within the essential services element of the community
WORKSAFE VICTORIA Pharmacy Policy (General) WorkSafe can pay the reasonable costs of medications and other pharmacy items required as a result of a work-related injury or illness in accordance with Victorian
Understanding Alberta s Drug Schedules Preface In May 2002, the provincial drug schedules to the Pharmaceutical Profession Act were amended. In April 2007, the Alberta Regulation 66/2007 to the Pharmacy
M.O. 23/2014 WHEREAS the Minister of Health is authorized pursuant to section 16 of the Regional Health Authorities Act to provide or arrange for the provision of health services in any area of Alberta
POLICY STATEMENT 5.17 DENTAL RECORDS 1 (Including ADA Guidelines for Dental Records) 1. Introduction 1.1 Dentists have a professional and a legal obligation to maintain clinically relevant, accurate and
National Medication Safety Programme Medicine Reconciliation Obtaining the most accurate medicines list Learning Objectives After this session, you should be able to: 1. explain why at least two information
North Carolina Medicaid Special Bulletin An Information Service of the Division of Medical Assistance Please visit our Web site at www.ncdhhs.gov/dma July 2007 ATTENTION: All Providers Notice of Change
Buying a Pharmacy CHECKLIST Do you know where to find advice and support? q PHARMACY GUILD MEMBERSHIP Don t forget to apply for Guild Membership. For information on the many benefits of Guild Membership
Community Pharmacy Roadmap Program Development Template Program/Service: Quadrant: Pharmacist Only Medicine Notifiable (POMN) B- Pharmacy medicines and health products services and programs 1. Program/Service
Guidance for Pharmacists on the Safe Supply of Methadone 1. Introduction The purpose of this guidance is to remind registered pharmacists involved in the supply of methadone, and the provision of associated
HIGHLY SPECIALISED DRUGS PROGRAM AND HERCEPTIN PROGRAM Western Australia Administrative Guidelines Pharmaceutical Services Branch Health Protection Group Table of Contents BACKGROUND...1 Overview...1 AHMAC
Pharmacy Technician Structured Practical Training Program Logbook This logbook outlines the activities that pharmacy technician learners are required to complete in order to demonstrate competencies as
Hospital pharmacy technician role / service definition grid To be a competent hospital pharmacy technician, you must be able to complete the required task to the defined standard and to do this on every
Licensed Scope of Practice Adapted from: Request for Regulation of s Approved by Council April 24, 2015 Definitions In this policy: Act means The Pharmacy and Pharmacy Disciplines Act means an unregulated
Do we have a common understanding of medication errors? Editor Meyler s Side Effects of Drugs Jeffrey Aronson Co-editor: Stephens Detection and Evaluation of Adverse Drug Reactions Side Effects of Drugs
GUIDELINES GUIDELINES ON PREVENTING MEDICATION ERRORS IN PHARMACIES AND LONG-TERM CARE FACILITIES THROUGH REPORTING AND EVALUATION Preamble The purpose of this document is to provide guidance for the pharmacist
1 11 MEDICATION MANAGEMENT OVERVIEW OF MEDICATION MANAGEMENT Depending on the size, structure and functions of the health facility, there may be a pharmacy with qualified pharmacists to dispense medication,
Quality Care Pharmacy Program An initiative of The Pharmacy Guild of Australia Supporting Excellence in Pharmacy April May 2011 THE PATIENT CHARTER A KEY AGREEMENT DELIVERABLE PHARMACY OF THE YEAR WINNER
PHARMACY DEPARTMENT POSITION DESCRIPTION POSITION TITLE Pharmacist Grade 1 REPORTS TO AWARD/AGREEMENT/CONTRACT As per organisational structure Hospital Pharmacists POSITION TYPE e.g. Registered Nurse Div
Medication Management Guidelines for Nurses and Midwives 1. Introduction As the statutory body responsible for the regulation of nursing and midwifery practice in Western Australia (WA), the Nurses & Midwives
NHS FORTH VALLEY Safer Lithium Dispensing Guidance Approved January 2013 Version Version 3 Date of First Issue March 2011 Review Date December 2014 Date of Issue January 2013 EQIA Yes / No March 2011 Author
Compensation Plan for Pharmacy Services Attachment A Section 1 - Definitions ABC Pharmacy Agreement means an agreement between ABC and a Community Pharmacy as described in Schedule 2.1 of the Alberta Blue
Breakfast symposium: From hospital to home - the focus on the patient Nadya Hamedi DARZI Fellow UCLPartners and Barts Health NHS Trust in collaboration with North Central London Local Pharmaceutical Committee
GUIDELINES ON DOSE ADMINISTRATION AIDS AND STAGED SUPPLY OF DISPENSED MEDICINES September 2015 PharmBA1507 05 Contents Introduction...3 Who needs to use these guidelines?...3 What happens if I do not comply
Leeds Humulin R (U500) insulin: Prescribing Guidance Amber Drug Level 2 We have started your patient on Humulin R (U500) insulin for the treatment of diabetic patients with marked insulin resistance requiring
Pre APPE Core Performance Domains and Abilities November, 2010 After release of the IPPE Competency Task Force Report in July 2009, AACP established a working group consisting of leaders and members of
Reducing Medical Errors with an Electronic Medical Records System A recent report by the Institute of Medicine estimated that as many as 98,000 people die in any given year from medical errors in hospitals
Outpatient Prescription Drug Benefit GENERAL INFORMATION This supplemental Evidence of Coverage and Disclosure Form is provided in addition to your Member Handbook and Health Plan Benefits and Coverage
Guidelines for Education Requirements for Recognition as Eligible Midwives and Accreditation Standards for programs of study leading to endorsement for scheduled medicines for Eligible Midwives 6447 Contents
Blue Cross and Blue Shield of Illinois Provider Manual Pharmacy Benefit Management Section 2016 Blue Cross and Blue Shield of Illinois, a Division of Health Care Service Corporation, a Mutual Legal Reserve
Last Name: Pharmacy Program Pre-Test * For each question, put a check mark for the one option that you think is correct. 1. A pharmacist receives a security prescription from a known local medical group
Consumer, Physician, and Payer Perspectives on Primary Care Medication Management Services with a Shared Resource Pharmacists Network Marie Smith, PharmD and Michlle Breland, PhD University of Connecticut,
File No.: 20100701 Guidelines for the Administration of certain substances by aged-care workers in residential aged care services 1 September 2010 Contents 1. Introduction...4 2. Regulation 95EA...5 3.
Drug treatment pathway for Osteoporosis in Postmenopausal Women Version 1.0 Ratified by: East Sussex HEMC Date ratified: 26.01.2011 Job title of originator/author Gillian Ells, East Sussex HEMC Pharmacist
healthcare associated infection A C T I O N G U I D E 1.2 AUSTRALIAN SAFETY AND QUALITY GOALS FOR HEALTH CARE What are the goals? The Australian Safety and Quality Goals for Health Care set out some important
Managing Medicines Access Programs Guiding principles for the governance of Medicines Access Programs in Australian hospitals May 2015 Council of Australian Therapeutic Advisory Groups Address: c/ - NSW
Nurse Led systemic monitoring clinics guidance on setting up this service Introduction Nurse led systemic monitoring clinics are an innovative approach to improving care delivery and maintaining both a
GUIDELINES FOR THE CONTROL AND ADMINISTRATION OF MEDICINES DOMICILIARY CARE AGENCIES January 2009 Contents Page Number 1.0 Introduction 3 2.0 Background 4 3.0 Criteria 5 3.1 Referral 5 3.2 Levels of assistance/consent
Issue: June 2009 PROFESSIONAL AND GUIDANCE FOR THE SALE AND SUPPLY OF MEDICINES PROFESSIONAL AND GUIDANCE FOR THE SALE AND SUPPLY OF MEDICINES CONTENTS Status of this document About this document 1 Pharmaceutical
Quality Care Pharmacy Program An initiative of The Pharmacy Guild of Australia Supporting Excellence in Pharmacy May June 2012 ONE PHARMACY S INTEGRATED APPROACH TO PROFESSIONAL SERVICES EMPLOYMENT DOCUMENTATION
Medicines reconciliation on admission and discharge from hospital policy April 2013 WHSCT medicines reconciliation policy 1 Policy Title Policy Reference Number Medicines reconciliation on admission and
Best Practice Recommendation for Exchanging & Processing about Pharmacy Benefit Management Version 091714a Issue Date Version Explanation Table of Contents Improvement Opportunity:... 1 Summary of Recommendation:...
For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,
Pharmacist independent prescribing programme learning outcomes and indicative content Learning outcomes All providers of GPhC accredited independent prescribing programmes need to ensure that following
A competency framework for all prescribers updated draft for consultation Consultation closes 15 April 2016 Contents 1 Introduction... 3 2 Uses of the framework... 4 3 Scope of the competency framework...
Draft guidance for registered pharmacies providing internet and distance sale, supply or service provision September 2014 1 The General Pharmaceutical Council is the regulator for pharmacists, pharmacy
Nurse Initiated STI Treatment Code Public Health and Clinical Services Division June 2012 FORWARD The Nurse Initiated STI Treatment Code establishes the competencies which must be achieved and criteria
PHARMACY TECHNICIAN STRUCTURED PRACTICAL TRAINING PROGRAM 1. Welcome Welcome to the Alberta College of Pharmacists Pharmacy Technician Structured Practical Training (SPT) program. The Pharmacists and Pharmacy
Value of Medication Therapy Management (MTM) Services from a Pharmaceutical Care Provider's Perspective Introduction In 2003, the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) identified
Pharmacy and Therapeutics Committee Policies and Procedures I. Charter... p 2 II. Formulary Principles... p 3 III. Drug Review Process... p 4 7 A. When are Medications Reviewed B. How Are Medications Reviewed
ISSUE DATE April 8, 2011 EFFECTIVE DATE April 8, 2011 MEDICAL ASSISTANCE BULLETIN NUMBER 03-11-01, 09-11-02, 14-11-01, 18-11-01 24-11-03, 27-11-02, 31-11-02, 33-11-02 SUBJECT Electronic Prescribing Internet-based
Quality Care Pharmacy Program An initiative of The Pharmacy Guild of Australia Supporting Excellence in Pharmacy September October 2012 KEY FINDINGS FROM THE QCPP COMMUNICATION SURVEY DISEASE STATE MANAGEMENT
PLAN POLICY AND PROCEDURE Title: Pharmacy Management Procedure for Pharmaceutical Patient Safety Division(s): Health Services Product Line (check all that apply): All Group HMO Individual HMO PPO POS N/A
Medication Utilization Understanding Potential Medication Problems of the Elderly NICE - National Initiative for the Care of the Elderly WHAT ARE MEDICATION UTILIZATION PROBLEMS AMONG THE ELDERLY? A useful
Practice Standards and Guidelines for Nurses and Midwives with Prescriptive Authority SEPTEMBER 2010 Contents INTRODUCTION 3 Medicines Legislation for Nurse/Midwife Prescribing 3 Professional Regulation
GUIDELINES FOR THE FUNDING OF EXCEPTIONAL DRUGS IN NSW & QUEENSLAND PRIVATE HOSPITALS Version 3 December 2008 EFFECTIVE DECEMBER 1996 & 1 st Revision JULY 2004 2 nd Revision December 2008 Approved by NSW/QUEENSLAND
The Academy of Managed Care Pharmacy s Concepts in Managed Care Pharmacy Medication Errors Medication errors are among the most common medical errors, harming at least 1.5 million people every year. The
Ernest Boyd, R.Ph., MBA Executive Director Ohio Pharmacists Association CDC s Guide for Pharmacist Partnership for Public Health Brief overview of Pharmacists All graduate with 6 to 8 year Doctor of Pharmacy
Consultation: Two proposals for registered nurse prescribing Submission Form Please read and refer to the consultation document Two proposals for registered nurse prescribing available on the Nursing Council
Executive Summary Cardiovascular health is a National Health Priority Area. Cardiovascular disease is the largest cause of premature death and death overall in Australia, and its health and economic burden
The Royal Pharmaceutical Society believes that better utilisation of pharmacists skills in care homes will bring significant benefits to care home residents, care homes providers and the NHS. Introduction
Pharmacy Guild Short Courses QCPP Refresher Training Meet QCPP SIRCHCS201 Support the supply of Pharmacy Medicines and Pharmacist This single unit meets the for QCPP for all staff who supply Pharmacy Medicines
Accredited Checking Technician (ACT) Standard Operating Procedures Standard Operating Procedures (SOP) 09/07 Standard Operating Procedures: For use in a pharmacy with an ACT (Accredited Checking Technician)
Complete the enrollment form on the reverse side to join Onyx 360 today. Oncology Nurse Advocates are available Monday through Friday, from 9 am to 8 pm Eastern Standard Time at 1-855-ONYX-360 (1-855-669-9360)
PHARMACY TECHNICIAN STRUCTURED PRACTICAL TRAINING (SPT) - GUIDE Goals This structured practical training program is intended to ensure candidates understand and meet the competencies and standards of practice
Page 1 of 6 patient medical records and eligibility available at the moment of prescribing and dispensing the medication. Serving the insured population in Dubai What is an e-prescription? It is the computer-based
Consultation: Two proposals for registered nurse prescribing Submission Form Please read and refer to the consultation document Two proposals for registered nurse prescribing available on the Nursing Council
Clinical Ordering, Receipt, Losses or Discrepancies, Diversion and Disposal of Medicines: SOP Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy
: I. PURPOSE The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics to ensure that adequate safeguards are in place
Exceptions and Appeals for Drug Therapies: A Guide for Healthcare Providers Table of Contents Introduction... 5 Prior Authorization... 7 Overview... 7 Step Therapy... 7 Quantity Limits... 7 The Prior Authorization
Pharmaceutical Care Lectures Jay D. Currie, Pharm.D. Fall 2006 History of the development of the pharmaceutical care model clinical pharmacy practice - 1960's move toward "patient-oriented practice" away
Background Over the Counter Drugs (OTCs): Considerations for Physical Therapy Practice in Canada The use of medications or drugs by non-physician health professionals is evolving and is linked to collaboration
PHARMACEUTICAL MANAGEMENT PROCEDURES THE FORMULARY The purpose of Coventry Health Care s formulary is to encourage use of the most cost-effective drugs. The formulary is necessary because the cost of prescription
9 The role of the pharmacy service Authors: Margaret Duguid and David Kong 9.1 Key points Pharmacists are essential to the success of antimicrobial stewardship programs and have a positive effect on improving